Piershale Financial Group’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-54,791	Closed	-$2.13M	–	169
2014 Q2	$2.13M	Sell	54,791 -21,398	-28%	-$833K	1.74%	15
2014 Q1	$2.61M	Buy	+76,189	New	+$2.61M	3.04%	20